Tag archive for ‘Tumor’
Roche launches Elecsys Anti-p53 immunoassay to help in cancer diagnosis
By businessnewstoday On Sunday, April 11th, 2021
0 Comments

Roche launches Elecsys Anti-p53 immunoassay to help in cancer diagnosis

Swiss healthcare company Roche has launched the Elecsys Anti-p53 immunoassay to help in the diagnosis of various types of cancer by the in vitro quantitative determination of anti-p53 antibodies. The Anti-p53 immunoassay More...

By pharmanewsdaily On Saturday, September 12th, 2020
0 Comments

Gan & Lee gets FDA orphan drug status for GLR2007 in malignant glioma

Gan & Lee Pharmaceuticals has been given orphan drug designation from the US Food and Drug Administration (FDA) for GLR2007 for the treatment of malignant glioma, an aggressive primary brain tumor. According More...

By pharmanewsdaily On Monday, July 27th, 2020
0 Comments

AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062

AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development and commercialization for the latter’s DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed More...

By pharmanewsdaily On Sunday, May 17th, 2020
0 Comments

Deciphera gets Qinlock FDA approval for fourth-line advanced GIST

Qinlock FDA approval : Deciphera Pharmaceuticals has been granted approval from the US Food and Drug Administration (FDA) for Qinlock (ripretinib) in advanced gastrointestinal stromal tumor (GIST) in adult patients More...

By pharmanewsdaily On Tuesday, May 12th, 2020
0 Comments

HKBU-led researchers develop EBV drug for nasopharyngeal cancer

A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus (EBV) drug for the treatment of nasopharyngeal cancer and other EBV-related cancers. The novel More...

By pharmanewsdaily On Saturday, May 9th, 2020
0 Comments

Selpercatinib FDA approval : Lilly’s therapy approved for treatment of lung and thyroid cancers with RET alteration

Selpercatinib FDA approval : The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Retevmo (selpercatinib) capsules for the treatment of three types of tumors – non-small cell lung More...

By pharmanewsdaily On Tuesday, November 5th, 2019
0 Comments

Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn

US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per the latest pharma acquisition news. The Beijing-based BeiGene is More...

By pharmanewsdaily On Wednesday, May 9th, 2018
0 Comments

Know about special characteristics of cancer cells

Cancer cells have special characteristics than the normal cells and you can know what are the special characteristics of the cancer cells below. The special characteristics of cancer cells are: Uncontrolled proliferation Apoptosis More...

By pharmanewsdaily On Monday, December 2nd, 2013
0 Comments

What is meant by metastasis? What are the common sites for metastasis?

What is meant by metastasis? Metastasis is the ability of the tumor cells to spread to other parts of the body and establish secondary tumors. Malignant tumors break loose from the mass and spread to other parts More...

By pharmanewsdaily On Tuesday, November 19th, 2013
0 Comments

What is the difference between Cancer and Tumor?

What is meant by Cancer? Cancer is a large, heterogenous class of diseases, characterized by uncontrolled growth of cells that invade the surrounding tissues and destroys them. English: Macrophages intake the nanoshells More...